Skip to content
インタ―システムズ製品やソリューション、キャリアの機会などについて、検索してご覧ください。

Healthcare AI’s Next Challenge: Earning Trust in the Real World

Industry Insights

Two coworkers laptop at office meeting.

Healthcare Focus on AI Evidence

Healthcare leaders have moved beyond asking whether artificial intelligence can produce impressive demonstrations. The more important question is whether AI can improve clinical work in measurable, repeatable, and trusted ways. That shift marks the beginning of a new phase for healthcare technology: The AI Evidence.

In this era, innovation is no longer enough. Health systems need practical proof that AI reduces administrative burden, improves access to information, strengthens clinician-patient interaction, and supports safer, more confident decision-making without removing human accountability. The organizations that succeed will be those that combine AI capability with governance, workflow integration, clinician trust, and real-world evaluation.

Independent research conducted by Angelica Marotta, Ph.D., Research Affiliate, Massachusetts Institute of Technology, Sloan School, Founder & Director, AM Academic Consulting, LLC examining InterSystems IntelliCare® at Elang Medika Corpora (EMC) Healthcare in Indonesia provides an early view into this transition. The study followed clinicians before deployment, after deployment, and during ongoing use, capturing both measurable outcomes and the human experience of AI in clinical practice.

InterSystems IntelliCare in Brief

InterSystems IntelliCare is an AI-native EHR and healthcare information system built on InterSystems experience with enterprise clinical and data management platforms. InterSystems IntelliCare embeds AI directly into user workflows, enabling clinicians to use natural language to retrieve patient information, generate summaries, support documentation, and streamline routine actions within the EHR environment. Rather than adding a separate AI layer outside the clinical record, InterSystems IntelliCare is designed to help reduce workflow friction while preserving human review, clinical accountability, and governance.

Dr. Bella Desra Andae
Head of Medical Informatics
EMC Healthcare

Evidence in Practice: EMC Healthcare

EMC Healthcare operates an eight-hospital network in Indonesia with more than 1,400 beds and more than 600,000 patient visits per year. Following its long-standing use of InterSystems TrakCare®, EMC moved to AI-native workflows with the implementation of InterSystems IntelliCare EHR.

The research used a longitudinal, mixed-methods design across phases of deployment. Quantitative methods included structured surveys and defined performance indicators, while qualitative methods included semi-structured interviews, observations, and clinician feedback. The study examined clinical efficiency, patient interaction quality, information management, clinical decision support, security and compliance, overall system value and satisfaction, and Indonesian contextual fit.

What the Results Showed

The study results suggest that AI-native workflows can deliver meaningful improvements when AI is embedded into the EHR and aligned with clinical practice.

Several quantitative findings stand out. AI-assisted information retrieval decreased from more than seven minutes to approximately one to two minutes. Manual documentation time decreased by 38% in association with ambient workflows. AI automation was reported to handle approximately 52% of routine documentation tasks. Clinicians reported a moderate improvement in job satisfaction, a moderate decrease in documentation-related burnout, and a high willingness to recommend the system, with recommendation likelihood reported at 3.5 on a four-point scale.

Other operational indicators reinforce the broader pattern. Hands-free documentation was associated with improved eye contact for approximately 63% of clinicians, and some clinicians reported being able to see two to five additional patients per day depending on specialty, workflow, and patient complexity.

The qualitative findings are equally important. Before InterSystems IntelliCare implementation, clinicians described EHR work as a significant cognitive and administrative burden. Some reported that computer work consumed 50% to 70% of their time, that maintaining eye contact during consultations was difficult while typing, and that finding fragmented patient information could affect clinical reasoning. After deployment, clinicians described AI as removing friction from everyday practice: less time documenting, less time searching, fewer interruptions, and more ability to focus on the patient.

That qualitative theme may be the most important result. The greatest value of healthcare AI may not always be highly visible. It may be felt as reduced friction: fewer transitions, fewer searches, less after-hours documentation, improved attention, and more natural clinical conversations.

AI-Enabled Clinical Workflow Outcomes table
Table 1: High-Level Research Results at EMC

The Invisible Impact of EHR with
Embedded AI

Results reveal that InterSystems IntelliCare did not create value through one dramatic change. It created cumulative value by removing small, repeated points of friction: clicks avoided, easier navigation, histories surfaced faster, notes drafted sooner, summaries structured earlier, and clinicians able to spend more of the encounter focused on the patient.

That “invisible impact” may be most important lens for interpreting the EMC results. In a Fireside Chat discussion, Dr. Marotta noted that clinicians rarely described AI in terms of individual features. They described the outcomes: spending less time at the computer, seeing more patients, interacting more naturally with patients, having more time for clinical reasoning, and feeling less distracted during consultations. In other words, the technology became most valuable when it became a normalized part of care delivery workflows.

Angelica Marotta, Ph.D.
Research Affiliate, Massachusetts Institute of Technology, Sloan School
Founder & Director, AM Academic Consulting, LLC

Trust: The Real Measure of AI Maturity

The research shows that trust in healthcare AI is calibrated, not granted wholesale. Clinicians were most confident when AI supported familiar workflows, made information easier to access, reduced routine effort, and kept final judgment in their hands. AI-generated notes, ambient documentation, and decision-support tools were valuable because they could help retrieve, summarise, and structure information while preserving clinician review, accountability, and oversight.

At the same time, confidence remained dependent on transparency, defensibility, source clarity, and reliable performance in real-world care settings. Decision support showed promise, but clinicians were more cautious when AI moved from documentation and retrieval toward interpretation or recommendation. These findings reinforce that successful adoption is not about replacing clinicians or eliminating review; it is about augmenting clinical work while making verification more efficient and targeted.

The research also underscores that compliance alone does not create clinical trust. Governance, education, transparency, and human oversight are needed to translate regulatory confidence into day-to-day clinician confidence, ensuring AI operates as a dependable support layer rather than a source of blind reliance.

Five Lessons for Healthcare Leaders

  1. Put workflow before algorithms
    AI creates value when it removes friction from the work clinicians already need to do. Embedding AI inside the EHR is therefore strategically different from adding disconnected tools around it. The objective should be fewer interruptions, fewer searches, and faster access to the information clinicians need at the point of care.
  2. Measure cognitive burden, not only productivity
    Time saved and clicks reduced are important, but they do not capture the full impact of AI. Healthcare organisations should also measure clinician attention, documentation burden, after-hours work, confidence, patient interaction quality, and adoption momentum.
  3. Treat trust as an implementation outcome
    Trust is not installed with software. It is earned through transparent design, training, governance, human review, and the ability for clinicians to understand and verify what AI produces. Organisations should plan for trust-building as deliberately as they plan for technical deployment.
  4. Preserve clinicians in the loop
    The findings support an augmented-care model rather than an autonomous-care model. AI should help clinicians work with more context and less friction, while clinicians retain accountability for interpretation, validation, and final decisions.
  5. Build evidence into the AI strategy
    The next wave of healthcare AI adoption will depend on proof. Longitudinal research, clinician feedback, structured metrics, and continuous refinement will become competitive advantages for health systems seeking to scale AI responsibly.
The Strategic Takeaway

The EMC Healthcare research suggests that the future of healthcare AI will not be determined by technology alone. It will be shaped by whether AI fits naturally into clinical work, whether clinicians trust it, whether governance makes adoption safer, and whether outcomes can be measured in real healthcare environments.

For InterSystems, this points to the importance of AI-native design. When AI is embedded inside the EHR, it can become part of the clinical workflow rather than another system to manage. When combined with human oversight and evidenceled implementation, AI has the potential to reduce burden, improve access to information, support better patient interactions, and help healthcare organisations move toward more intelligent, patient-centred care.

The evidence era is still early. But one lesson is already clear: healthcare AI succeeds when it strengthens the relationship between clinicians, patients, and information. The goal is not technology for its own sake. The goal is care delivery with less friction, more confidence, and people firmly at the centre.


免責条項: InterSystems® のソフトウェア、関連サービス、資料、および専門知識は、人工知能の能力および機能を利用する場合があります。 詳細については、 AIの透明性に関するお知らせ、AI ガイドライン、製品ドキュメント、および該当する 使用目的記述 を参照してください。 SRN: DE-AR-000005430

InterSystems Corporation: One Congress Street, Boston, MA 02114-2010, USA.

あなたが好きかもしれない他のリソース

2026年 9月 19日
基礎編
概要 ある眼科手術センターでは、患者数が減少していました。 他院に奪われるのではなく、予約しても来院しない事象です。 毎週、予約された診察の18%が未受診でした。 4人の常勤スタッフが、約500人の患者に電話をかけ、予約の確認に一日中奔走しました。 それがうまくいかなかったため、クリニックは数字が合うことを期待して、無作為に予約枠を上回って受け付けました。 ある日は、患者さんが全員来院し、待合室は大混乱になることがありました。 それ以外の日は、予約枠が空いたままでした。
2026年 9月 19日
基礎編
医療分野における会話型AIは、緊急度タグ付け、AIを活用した自動返信、およびインテリジェントなメッセージルーティングにより、患者ポータルへの負担を軽減しています。 何が導入されているのか、またその実証結果がどのようなものかを確認しましょう。
2026年 9月 19日
基礎編
エージェント型AIアーキテクチャでは、特定のタスクに専門化されたAIエージェントを割り当てることで、その総合的な成果が単一のモデルを凌駕します。 中核となる構成要素、パターン、意思決定の枠組みについて学びましょう。
2026年 9月 17日
国際モダンホスピタルショウ2026 ブースプレゼンテーション動画を公開しました。
「蒲郡市民病院が歩み出す内製化DX2.0 ~ 統合データ基盤(IDF)とローカルLLMが拓く、多目的かつ高度なAI活用への挑戦 ~」 蒲郡市民病院 デジタル医療推進室/
2026年 9月 17日
業界インサイト
医療分野で必要な飛躍的な進歩を実現するための鍵となるデータ統合 他業界の同業者から「なぜ医療分野ではデータが他の業界と同じように画期的な進展をもたらしていないのか」と尋ねられると、その答えの多くは、明白なとことにあります。すなわち、臨床データと管理データは依然として別々のシステムに保存されており、それぞれ異なる「デジタル言語」で「会話」しているからです。 これらを統合することは、次の段階の進歩――より質の高い医療、より良い患者体験、そしてより優れた業務パフォーマンスを同時に実現するための前提条件です。 幸いなことに、現在では、メディケア・メディケイドサービスセンター(CMS)による「Fast Healthcare Interoperability Resources(FHIR)」APIの義務化、全米品質保証委員会(NCQA)によるデジタル品質指標の採用、情報ブロッキング禁止措置の施行など、この統合を後押しする複数の取り組みが進められています。 しかし、医療保険プランや医療提供者は、これら2つの長年にわたるデータのサイロを、いくつかの新しいサイロと置き換えてしまうことのないよう注意する必要があります。
2026年 9月 17日
ソリューションの概要
在庫不足による処置の中止を減らす
2026年 9月 8日
大好評をいただきました 2025年10月7日(火)に開催した 第6回 InterSystems 医療 x IT セミナー 「すべてのデータを利用可能に ~データが支える医療と健康~」の講演動画を公開いたしました。
2026年 9月 3日
基礎編
医療分野におけるエージェント型AI あるマルチエージェントAIシステムが最近、希少な症例について80%以上の確率で正確に診断しました。 これは、経験豊富な人間の臨床医よりも4倍も優れています。 それは、どのAIよりも賢かったからという理由だけでそこにたどり着いたわけではありません。 これは、複数のエージェントが互いに議論を交わし、エラーが発見されるまで続けた結果、実現したものです。
2026年 9月 1日
Becker's Healthcare Report(ベッカーズ・ヘルスケア・レポート)
データは基盤である AIは巨額の投資を集めている技術ですが、パネリストたちは、そうした投資が成功するかどうかの決定的な要因は、依然としてデータにあるという点で一致しました。 正確で完全、かつ適切に管理されたデータがなければ、どんなに高度なAIツールであっても、有意義な結果を生み出すことは困難です。
2026年 9月 1日
基礎編
FHIRは、医療データの交換を変革するREST API規格です。 VA(退役軍人省)とFDA(食品医薬品局)が、有害事象の自動報告にFHIR APIをどのように活用しているか、そしてそれが貴院の医療システムにとってどのような意味を持つのかについてご紹介します。

次のステップへ

ぜひ、お話を聞かせてください。 詳細をご記入の上、送信してください。
*必須項目(英語でご記入ください)
強調表示は必須項目です。
*必須項目(英語でご記入ください)
強調表示は必須項目です。
** ここをチェックすることにより、お客様は、既存及び将来のインターシステムズ製品及びイベントに関するニュース、最新情報及びその他のマーケティング目的のために連絡を受けることに同意するものとします。 また、フォームを送信することで、お客様は、お客様のビジネス連絡先情報が、米国でホストされているが、適用されるデータ保護法に従って維持されている当社のCRMソリューションに入力されることに同意するものとします。